These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Role of complement in patients with autoimmune hemolytic anemia and platelet transfusion refractoriness. Fontaine MJ. Transfus Clin Biol; 2019 Sep 15; 26(3):152-154. PubMed ID: 31277985 [Abstract] [Full Text] [Related]
13. Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes. Atkinson JP, Schreiber AD, Frank MM. J Clin Invest; 1973 Jun 15; 52(6):1509-17. PubMed ID: 4703235 [Abstract] [Full Text] [Related]
14. Drug-induced immune hemolytic anemia. Garratty G. Hematology Am Soc Hematol Educ Program; 2009 Jun 15; ():73-9. PubMed ID: 20008184 [Abstract] [Full Text] [Related]
15. NIH conference. Pathophysiology of immune hemolytic anemia. Ann Intern Med; 1977 Aug 15; 87(2):210-22. PubMed ID: 329729 [Abstract] [Full Text] [Related]
16. [Hemolytic anemias induced by drug hypersensitivity]. Maas D, Schubothe H, Weber S. Folia Haematol Int Mag Klin Morphol Blutforsch; 1974 Aug 15; 101(3):372-83. PubMed ID: 4139057 [No Abstract] [Full Text] [Related]
17. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. Petz LD, Fink DJ, Letsky EA, Fudenberg HH, Müller-Eberhard J. J Clin Invest; 1969 Nov 15; 47(11):2469-84. PubMed ID: 4975569 [Abstract] [Full Text] [Related]
18. Phenacetin antibody cross-reactive with autoimmune erythrocyte antibody. Hart MN, Mesara BW. Am J Clin Pathol; 1969 Dec 15; 52(6):695-701. PubMed ID: 5353837 [No Abstract] [Full Text] [Related]
19. Correlation of in vivo and in vitro measurements of hemolysis in hemolytic anemia due to immune ractions. Rosse WF. Prog Hematol; 1973 Dec 15; 8():51-75. PubMed ID: 4799199 [No Abstract] [Full Text] [Related]